260 related articles for article (PubMed ID: 15841074)
1. Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ.
Wülfing P; Kersting C; Buerger H; Mattsson B; Mesters R; Gustmann C; Hinrichs B; Tio J; Böcker W; Kiesel L
Br J Cancer; 2005 May; 92(9):1720-8. PubMed ID: 15841074
[TBL] [Abstract][Full Text] [Related]
2. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
3. Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers.
Hieken TJ; Farolan M; D'Alessandro S; Velasco JM
Surgery; 2001 Oct; 130(4):593-600; discussion 600-1. PubMed ID: 11602889
[TBL] [Abstract][Full Text] [Related]
4. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis.
Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
J Pathol; 2001 Mar; 193(3):325-32. PubMed ID: 11241411
[TBL] [Abstract][Full Text] [Related]
5. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.
Takahashi Y; Cleary KR; Mai M; Kitadai Y; Bucana CD; Ellis LM
Clin Cancer Res; 1996 Oct; 2(10):1679-84. PubMed ID: 9816116
[TBL] [Abstract][Full Text] [Related]
6. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
Lee AH; Dublin EA; Bobrow LG; Poulsom R
J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
[TBL] [Abstract][Full Text] [Related]
7. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.
Brown LF; Berse B; Jackman RW; Tognazzi K; Guidi AJ; Dvorak HF; Senger DR; Connolly JL; Schnitt SJ
Hum Pathol; 1995 Jan; 26(1):86-91. PubMed ID: 7821921
[TBL] [Abstract][Full Text] [Related]
9. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
[TBL] [Abstract][Full Text] [Related]
10. Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues.
Pallares J; Rojo F; Iriarte J; Morote J; Armadans LI; de Torres I
Histol Histopathol; 2006 Aug; 21(8):857-65. PubMed ID: 16691538
[TBL] [Abstract][Full Text] [Related]
11. VEGF, bFGF and their receptors at the fetal-maternal interface of the rhesus monkey.
Wei P; Yu FQ; Chen XL; Tao SX; Han CS; Liu YX
Placenta; 2004; 25(2-3):184-96. PubMed ID: 14972451
[TBL] [Abstract][Full Text] [Related]
12. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops.
de Jong JS; van Diest PJ; van der Valk P; Baak JP
J Pathol; 1998 Jan; 184(1):44-52. PubMed ID: 9582526
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of lymphangiogenic and angiogenic factors in a model of breast ductal carcinoma in situ.
Yu M; Tang Z; Alousi S; Berk RS; Miller F; Kosir MA
Am J Surg; 2007 Nov; 194(5):594-9. PubMed ID: 17936419
[TBL] [Abstract][Full Text] [Related]
14. Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas.
Okada K; Osaki M; Araki K; Ishiguro K; Ito H; Ohgi S
Anticancer Res; 2005; 25(4):3003-9. PubMed ID: 16080559
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors.
Yonemaru K; Sakai H; Murakami M; Yanai T; Masegi T
Vet Pathol; 2006 Nov; 43(6):971-80. PubMed ID: 17099154
[TBL] [Abstract][Full Text] [Related]
16. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast.
Guidi AJ; Schnitt SJ; Fischer L; Tognazzi K; Harris JR; Dvorak HF; Brown LF
Cancer; 1997 Nov; 80(10):1945-53. PubMed ID: 9366297
[TBL] [Abstract][Full Text] [Related]
17. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Wang Z; Shi Q; Wang Z; Gu Y; Shen Y; Sun M; Deng M; Zhang H; Fang J; Zhang S; Xie F
Pathol Res Pract; 2011 Aug; 207(8):505-13. PubMed ID: 21802218
[TBL] [Abstract][Full Text] [Related]
19. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.
Perrone G; Santini D; Vincenzi B; Zagami M; La Cesa A; Bianchi A; Altomare V; Primavera A; Battista C; Vetrani A; Tonini G; Rabitti C
Histopathology; 2005 May; 46(5):561-8. PubMed ID: 15842638
[TBL] [Abstract][Full Text] [Related]
20. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]